Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patients

Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patients

Abstract Background The DecisionDx-Melanoma test provides prognostic information for patients with cutaneous melanoma (CM). Using formalin-fixed paraffin-embedded primary tumor tissue, the RT-PCR-based test classifies patients into a low- (Class 1) or high-risk (Class 2) category for recurrence base...

Full description

Bibliographic Details
Main Authors: Robert W. Cook, Brooke Middlebrook, Jeff Wilkinson, Kyle R. Covington, Kristen Oelschlager, Federico A. Monzon, John F. Stone
Format: Article
Language:English
Published: BMC 2018-02-01
Series:Diagnostic Pathology
Subjects:
Gene expression profiling
DecisionDx-Melanoma
Cutaneous melanoma
Metastasis
Analytic validity
Technical success
Online Access:http://link.springer.com/article/10.1186/s13000-018-0690-3

Internet

http://link.springer.com/article/10.1186/s13000-018-0690-3

Similar Items